CareDx Return on Tangible Equity 2013-2025 | CDNA

Current and historical return on tangible equity values for CareDx (CDNA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
CareDx Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.06B $0.30B 25.79%
2024-12-31 $0.05B $0.30B 25.00%
2024-09-30 $-0.15B $0.19B -80.77%
2024-06-30 $-0.16B $0.18B -77.42%
2024-03-31 $-0.19B $0.17B -76.15%
2023-12-31 $-0.19B $0.18B -66.73%
2023-09-30 $-0.09B $0.31B -27.40%
2023-06-30 $-0.08B $0.32B -24.67%
2023-03-31 $-0.08B $0.34B -23.14%
2022-12-31 $-0.08B $0.35B -21.43%
2022-09-30 $-0.08B $0.36B -20.46%
2022-06-30 $-0.07B $0.36B -18.56%
2022-03-31 $-0.05B $0.37B -12.87%
2021-12-31 $-0.03B $0.38B -7.84%
2021-09-30 $-0.02B $0.40B -5.38%
2021-06-30 $-0.01B $0.41B -3.29%
2021-03-31 $-0.02B $0.40B -5.98%
2020-12-31 $-0.02B $0.21B -12.56%
2020-09-30 $-0.02B $0.20B -18.34%
2020-06-30 $-0.02B $0.19B -28.07%
2020-03-31 $-0.02B $0.03B -71.79%
2019-12-31 $-0.02B $0.03B -68.15%
2019-09-30 $-0.02B $0.03B -56.41%
2019-06-30 $-0.04B $0.03B -100.00%
2019-03-31 $-0.05B $0.05B -157.26%
2018-12-31 $-0.05B $0.05B -348.15%
2018-09-30 $-0.08B $0.03B 625.00%
2018-06-30 $-0.07B $-0.02B 219.05%
2018-03-31 $-0.06B $-0.01B 166.20%
2017-12-31 $-0.06B $-0.05B 139.13%
2017-09-30 $-0.04B $-0.05B 113.87%
2017-06-30 $-0.03B $-0.03B 98.31%
2017-03-31 $-0.04B $-0.03B 120.69%
2016-12-31 $-0.04B $-0.03B 185.71%
2016-09-30 $-0.03B $-0.03B 252.17%
2016-06-30 $-0.03B $-0.03B 2800.00%
2016-03-31 $-0.02B $0.00B -182.61%
2015-12-31 $-0.01B $0.01B -80.00%
2015-09-30 $-0.01B $0.02B -41.56%
2015-06-30 $0.00B $0.02B -19.05%
2015-03-31 $0.00B $0.02B 0.00%
2014-12-31 $0.00B $0.02B 50.00%
2014-09-30 $0.00B $0.02B 0.00%
2014-06-30 $0.00B $-0.02B 15.38%
2014-03-31 $0.00B $-0.02B 50.00%
2013-12-31 $0.00B $-0.02B 106.67%
Sector Industry Market Cap Revenue
Medical Medical Services $1.035B $0.334B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.614B 26.94
Elevance Health (ELV) United States $86.883B 11.21
CVS Health (CVS) United States $85.338B 10.61
Cencora (COR) United States $57.282B 19.93
DiDi Global (DIDIY) China $22.826B 24.25
Natera (NTRA) United States $22.577B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.669B 0.00
Solventum (SOLV) United States $12.768B 13.52
ICON (ICLR) Ireland $11.763B 10.94
CochLear (CHEOY) Australia $11.550B 0.00
Revvity (RVTY) United States $11.024B 18.97
Doximity (DOCS) United States $10.503B 48.63
Viatris (VTRS) United States $10.469B 3.60
HealthEquity (HQY) United States $9.059B 39.68
Avantor (AVTR) United States $8.906B 12.94
Medpace Holdings (MEDP) United States $8.572B 22.77
Sonic Healthcare (SKHHY) Australia $8.393B 0.00
Charles River Laboratories (CRL) United States $7.340B 14.38
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.361B 25.69
BrightSpring Health Services (BTSG) United States $3.724B 34.16
Sotera Health (SHC) United States $3.244B 18.44
Alignment Healthcare (ALHC) United States $2.956B 0.00
Surgery Partners (SGRY) United States $2.914B 37.90
Concentras Parent (CON) United States $2.749B 15.89
Organon (OGN) United States $2.610B 2.77
Ardent Health (ARDT) United States $1.881B 8.02
Premier (PINC) United States $1.858B 14.11
GeneDx Holdings (WGS) United States $1.842B 70.96
Progyny (PGNY) United States $1.803B 39.68
PACS (PACS) United States $1.573B 0.00
GoodRx Holdings (GDRX) United States $1.561B 31.21
Teladoc Health (TDOC) United States $1.203B 0.00
Pediatrix Medical (MD) United States $1.203B 9.15
Establishment Labs Holdings (ESTA) $1.083B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.890B 0.00
AMN Healthcare Services Inc (AMN) United States $0.826B 7.73
QDM (QDMI) Hong Kong, SAR China $0.763B 0.00
Nutex Health (NUTX) United States $0.679B 10.28
LifeMD (LFMD) United States $0.566B 0.00
Embecta (EMBC) United States $0.559B 3.76
Enhabit (EHAB) United States $0.495B 40.75
InnovAge Holding (INNV) United States $0.478B 0.00
Auna S.A (AUNA) Luxembourg $0.467B 10.52
SBC Medicals (SBC) United States $0.459B 0.00
Sonida Senior Living (SNDA) United States $0.453B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.411B 0.00
Performant Healthcare (PHLT) United States $0.255B 0.00
Oncology Institute (TOI) United States $0.220B 0.00
Beauty Health (SKIN) United States $0.193B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.148B 24.17
Pheton Holdings (PTHL) China $0.114B 0.00
So-Young (SY) China $0.097B 0.00
KindlyMD (NAKA) United States $0.083B 0.00
OncoCyte (OCX) United States $0.076B 0.00
Sera Prognostics (SERA) United States $0.064B 0.00
Basel Medical Group (BMGL) Singapore $0.064B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
Biodesix (BDSX) United States $0.042B 0.00
ModivCare (MODV) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00